SCHEMBL8287205

SCHEMBL8287205

NC(=O)c1cc2c(cn1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.37
CDK4 P11802 1/20 0.36
CCND1 P24385 1/20 0.36
CCND2 P30279 1/20 0.36
CCND3 P30281 1/20 0.36
CSF1R P07333 7/20 0.36
PDE11A Q9HCR9 1/20 0.35
LCK P06239 1/20 0.35
PDE4B Q07343 3/20 0.35
GRM2 Q14416 1/20 0.35
PDE4A P27815 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
JAK2 O60674 1/20 0.34
JAK1 P23458 1/20 0.34
TYK2 P29597 1/20 0.34
JAK3 P52333 1/20 0.34
IRAK4 Q9NWZ3 1/20 0.34
EGFR P00533 1/20 0.34
BTK Q06187 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287593 0.92 GSK3B (0.37) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8286468 0.90 GSK3B (0.38) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287526 0.89 MAPK13 (0.38) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8286472 0.89 EGFR (0.46) LCKEGFR
SCHEMBL8362924 0.87 GSK3B (0.39) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287920 0.87 CSF1R (0.37) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8285291 0.86 GABRA1 (0.40) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287936 0.85 RIPK1 (0.40) GSK3BPDE11ALCKEGFR
SCHEMBL8287197 0.84 EGFR (0.43) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287486 0.84 LMNA (0.37) GSK3BCDK4CCND1CCND2CCND3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed